Liminatus Pharma Competitors and Similar CompaniesClear all
Liminatus Pharma's competitors and similar companies include CEL-SCI.
 Liminatus Pharma Liminatus Pharma (formerly known as Iris Acquisition) is a pre‑clinical‑stage immuno‑oncology company. |  CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. | |
Founding Date | Founding Date 2018 | Founding Date 1983 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations La Palma, US HQ | Locations Vienna, US HQ |
Employees | Employees 1 | Employees N/A |
Financial | ||
Net income | Net income ($10.2m) (FY, 2025) | Net income ($25.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
CEL-SCI
HQ
Vienna, US
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View company